跳至主要内容
临床试验/NCT02752009
NCT02752009撤回不适用

Evaluation Of Axillary Lymph Node Metastases With Sentinel Lymph Node Biopsy After Neoadjuvant Therapy In Breast Cancer Patients

Dana-Farber Cancer Institute0 个研究点开始时间: 2016年4月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
主要终点
False Negative Rate (FNR) Of Sentinel Lymph Node Biopsy At The Time Of Surgery

研究概览

简要总结

This research protocol is studying the accuracy of the sentinel lymph node biopsy procedure in breast cancer patients who have cancer cells in the lymph nodes in the armpit (axilla) who have received chemotherapy or endocrine therapy prior to having surgery (neoadjuvant therapy).

详细描述

  • This research study is a Pilot Study, which is the first time investigators are examining this study intervention locally; although this intervention has been studied nationally in published clinical trials.
  • In this research study, the investigators are studying the accuracy of the sentinel lymph node biopsy procedure in breast cancer patients who have cancer cells in the lymph nodes in the armpit (axilla) who have received chemotherapy or endocrine therapy prior to having surgery (neoadjuvant therapy).
  • A sentinel lymph node biopsy is a surgical evaluation of the lymph nodes in the underarm area in patients who have early breast cancer. Approximately, two-five nodes are removed from the underarm area for evaluation. The sentinel lymph node biopsy is performed in patients with breast cancer to determine if there are cancer cells in the lymph nodes in the armpit.
  • The sentinel lymph node biopsy procedure is performed by injecting one or two dyes into the breast, which then travel to the armpit region via small vessels in the immune system. These nodes are called the sentinel lymph nodes. They represent the first nodes that drain the breast tissue. They are closely evaluated by a Pathologist to determine if cancer cells are present.
  • This information allows physicians to know how far the cancer may have spread and recommend therapies accordingly.
  • If sentinel lymph node biopsy is determined to be accurate in patients who are known to already have cancer cells in the axillary lymph nodes who receive neoadjuvant therapy, then in the future, many of the patients in this population may be spared the procedure of a full axillary lymph node dissection, which removes a larger number of lymph nodes and thus has increased risks and side-effects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible patients will include any patients with biopsy-proven breast cancer and biopsy-proven axillary lymph node metastases at Beth Israel Deaconess Medical Center who are candidates for Neoadjuvant Chemotherapy or Neoadjuvant Endocrine therapy.
  • A core needle biopsy or fine needle aspiration is acceptable for diagnosis of metastatic disease in lymph nodes.
  • Patients will be identified as possible participants in the Radiology Imaging suites and Breast Surgery Clinics.

排除标准

  • Patients with inflammatory breast cancer or distant metastases will be excluded from participating in this study

研究组 & 干预措施

Axillary Lymph Node Sampling Clip

Experimental
  • Axillary Lymph Node Biopsy

-- Axillary lymph node sampling with clip placement into the sampled lymph node. After the tissue sampling of any suspicious nodes, a marker clip will be placed to allow for intra-operative identification of the biopsied nodes.

  • Neoadjuvant therapy at the discretion of the treating Medical Oncologist. Once Neoadjuvant therapy is completed, surgery in the form of either Lumpectomy or Mastectomy is performed.

  • Wire-localization of the clipped node on the day of surgery.

  • Lymphatic mapping performed with either radiocolloid and/or blue dye.

  • Sentinel lymph node biopsy will be performed on the day of surgery.

--- If the clipped node which contains the wire is not part of this sentinel lymph node specimen, then it will be removed separately and be sent to Pathology as a separate specimen.

  • Axillary lymph node dissection as is the standard of care.

干预措施: Axillary Lymph Node Sampling Clip (Procedure)

结局指标

主要结局

False Negative Rate (FNR) Of Sentinel Lymph Node Biopsy At The Time Of Surgery

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ranja Sharma

Ranjna Sharma, M.D

Dana-Farber Cancer Institute

相似试验